Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking WHO Step III Analgesics But Showing a Lack of Tolerability

Stopped This clinical trial was terminated early, due to slow recruitment and study drug shortages.

Conditions

• Pain
• Chronic Pain
• Low Back Pain
• Neuropathic Pain
• Nociceptive Pain

Interventions

• DRUG: Tapentadol Prolonged Release

Sponsor

Grünenthal GmbH